Adma Biologics Inc (ADMA)

SG&A Expenses

$26.74M

Quarterly · Period ending: · USD

ADMA logo

ADMA SG&A Expenses

Latest reported$26.74M
ADMA Quarterly SG&A Expenses ($12.50K → $26.74M)
High-resolution chart · PNG

ADMA sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Adma Biologics Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
26,737,000
26,742,000
23,512,000
23,048,000
22,214,000
24,079,000
23,317,000
18,560,000
16,608,000
15,639,000
15,534,999
14,726,000
14,248,000
14,512,000
13,894,888
12,893,139
11,970,422
13,699,575
11,698,009
10,726,797
10,438,168
10,033,915
9,300,359
9,115,744
8,702,630
7,932,084
7,032,067
7,197,173
6,086,047
5,595,470
7,135,275
5,355,794
5,006,807
5,005,046
5,184,337
4,195,464
4,435,650
4,277,384
3,283,594
1,779,115
1,724,163
1,707,870
1,884,370
2,078,166
1,437,436
1,345,997
1,111,994
1,035,220
1,542,066
1,134,589
998,635
845,301
1,090,292
1,431,106
696,246
1,034,530
736,924
674,589
3,850
3,850
14,914
3,850
3,850
3,850
10,030
4,000
3,500
3,819,000
0
10,949,000
7,127,000
24,916,000
16,092,000
11,222,000
4,250
29,735,000
2,000
2,000
12,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.